Back to Search
Start Over
Outcomes of a mandatory non-medical switch of infliximab to a biosimilar for inflammatory bowel disease in British Columbia, Canada.
- Source :
- Journal of the Canadian Association of Gastroenterology; Aug2024, Vol. 7 Issue 4, p299-305, 7p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 25152092
- Volume :
- 7
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Journal of the Canadian Association of Gastroenterology
- Publication Type :
- Academic Journal
- Accession number :
- 179110728
- Full Text :
- https://doi.org/10.1093/jcag/gwae011